Europe

Read full text Summarise with VIRAT
Authors: Wim van Harten, Silvia Brotea-Mosoiu, Tania Cufer, Sabine Siesling, Didier Verhoeven
Cited by: 0
References: 12

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Countries cherish and protect their national competence on healthcare provision and system choices, and so far, national choices on quality regulation, concentration, and networking are dominant. A certain degree of- and gradual alignment between countries is to be expected. Apart from the earlier COVID experiences, the EU Beating Cancer Plan, with initiatives such as working on Comprehensive Cancer Infrastructures, the European Commission Initiative on Breast Cancer (ECBIC, by the Joint Research Centre, JRC), initiatives from professional societies such as EUSOMA and publications on differences in access, costs, and survival will inevitably have effect on a very gradual shift towards new balances in EU and national competences. There are differences in spending, availability of medical technology and drug access related to breast cancer over EU countries that lead to inequalities in availability of facilities for screening and treatment. In this chapter, we present the roles and responsibilities of governments and executives, as well as the role of professional organizations relating to breast cancer.

Fields of Study & Subjects

Healthcare Systems and Practices Healthcare Regulation Health Services Management and Policy

Publication details

Journal / source
Oxford University Press eBooks
Pages
387–398
Publication date
1 March 2026
Language
EN
Document type
Book chapter